Orvain, Cindy
Cauvet, Anne
Prudent, Alexis
Guignabert, Christophe
Thuillet, Raphaël
Ottaviani, Mina
Tu, Ly
Duhalde, Fanny
Nicco, Carole
Batteux, Frédéric
Avouac, Jérôme
Wang, NingXin
Seaberg, Michelle A.
Dillon, Stacey R.
Allanore, Yannick
Funding for this research was provided by:
Alpine Immune Sciences
Article History
Received: 21 September 2021
Accepted: 20 December 2021
First Online: 5 January 2022
Declarations
:
: All patients and volunteer blood donors signed a consent form approved by the local institutional review boards [CPP (Comité de Protection des Personnes) Paris Ile de France 3; Convention INSERM, Etablissement français du sang]. Animal protocols used in this study were reviewed and approved by the Ethics committee of our university (Fra-2 protocol : 2019070110126-750V5; HOCL protocol : 2019080816497351).
: Not applicable.
: YA received consulting honorarium from Bayer, Boehringer, Roche, Celltrion, and Sanofi with regard to the management and treatment of systemic sclerosis. NW, MAG, and SRD are employees and shareholders of Alpine Immune Sciences.